132 related articles for article (PubMed ID: 37952715)
21. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
[TBL] [Abstract][Full Text] [Related]
22. Muscle LIM Protein Force-Sensing Mediates Sarcomeric Biomechanical Signaling in Human Familial Hypertrophic Cardiomyopathy.
Riaz M; Park J; Sewanan LR; Ren Y; Schwan J; Das SK; Pomianowski PT; Huang Y; Ellis MW; Luo J; Liu J; Song L; Chen IP; Qiu C; Yazawa M; Tellides G; Hwa J; Young LH; Yang L; Marboe CC; Jacoby DL; Campbell SG; Qyang Y
Circulation; 2022 Apr; 145(16):1238-1253. PubMed ID: 35384713
[TBL] [Abstract][Full Text] [Related]
23. A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.
Seeger T; Shrestha R; Lam CK; Chen C; McKeithan WL; Lau E; Wnorowski A; McMullen G; Greenhaw M; Lee J; Oikonomopoulos A; Lee S; Yang H; Mercola M; Wheeler M; Ashley EA; Yang F; Karakikes I; Wu JC
Circulation; 2019 Feb; 139(6):799-811. PubMed ID: 30586709
[TBL] [Abstract][Full Text] [Related]
24. Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy.
Cashman TJ; Josowitz R; Johnson BV; Gelb BD; Costa KD
PLoS One; 2016; 11(1):e0146697. PubMed ID: 26784941
[TBL] [Abstract][Full Text] [Related]
25. Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells.
Han L; Li Y; Tchao J; Kaplan AD; Lin B; Li Y; Mich-Basso J; Lis A; Hassan N; London B; Bett GC; Tobita K; Rasmusson RL; Yang L
Cardiovasc Res; 2014 Nov; 104(2):258-69. PubMed ID: 25209314
[TBL] [Abstract][Full Text] [Related]
26. Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling.
Vučković S; Dinani R; Nollet EE; Kuster DWD; Buikema JW; Houtkooper RH; Nabben M; van der Velden J; Goversen B
Stem Cell Res Ther; 2022 Jul; 13(1):332. PubMed ID: 35870954
[TBL] [Abstract][Full Text] [Related]
27. Speckle-Tracking Strain Analysis for Mapping Spatiotemporal Contractility of Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocytes.
Izadifar M; Berecz T; Li B; Tang JKKY; Foldes G; Apati A; Nagy A
Curr Protoc; 2023 Sep; 3(9):e889. PubMed ID: 37747346
[TBL] [Abstract][Full Text] [Related]
28. Autonomous and Non-autonomous Defects Underlie Hypertrophic Cardiomyopathy in BRAF-Mutant hiPSC-Derived Cardiomyocytes.
Josowitz R; Mulero-Navarro S; Rodriguez NA; Falce C; Cohen N; Ullian EM; Weiss LA; Rauen KA; Sobie EA; Gelb BD
Stem Cell Reports; 2016 Sep; 7(3):355-369. PubMed ID: 27569062
[TBL] [Abstract][Full Text] [Related]
29. MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling.
Li X; Lu WJ; Li Y; Wu F; Bai R; Ma S; Dong T; Zhang H; Lee AS; Wang Y; Lan F
Cell Death Dis; 2019 Aug; 10(8):610. PubMed ID: 31406109
[TBL] [Abstract][Full Text] [Related]
30. Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state.
Vander Roest AS; Liu C; Morck MM; Kooiker KB; Jung G; Song D; Dawood A; Jhingran A; Pardon G; Ranjbarvaziri S; Fajardo G; Zhao M; Campbell KS; Pruitt BL; Spudich JA; Ruppel KM; Bernstein D
Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34117120
[TBL] [Abstract][Full Text] [Related]
31. Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome.
Jaffré F; Miller CL; Schänzer A; Evans T; Roberts AE; Hahn A; Kontaridis MI
Circulation; 2019 Jul; 140(3):207-224. PubMed ID: 31163979
[TBL] [Abstract][Full Text] [Related]
32. Contractility and Calcium Transient Maturation in the Human iPSC-Derived Cardiac Microfibers.
Strimaityte D; Tu C; Yanez A; Itzhaki I; Wu H; Wu JC; Yang H
ACS Appl Mater Interfaces; 2022 Aug; 14(31):35376-35388. PubMed ID: 35901275
[TBL] [Abstract][Full Text] [Related]
33. Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy.
Coppini R; Santini L; Olivotto I; Ackerman MJ; Cerbai E
Cardiovasc Res; 2020 Jul; 116(9):1585-1599. PubMed ID: 32365196
[TBL] [Abstract][Full Text] [Related]
34. Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes.
Gao Y; Su L; Wei Y; Tan S; Hu Z; Tao Z; Kovalik JP; Soong TW; Zhang J; Pu J; Ye L
Theranostics; 2023; 13(11):3872-3896. PubMed ID: 37441603
[No Abstract] [Full Text] [Related]
35. The Junctophilin-2 Mutation p.(Thr161Lys) Is Associated with Hypertrophic Cardiomyopathy Using Patient-Specific iPS Cardiomyocytes and Demonstrates Prolonged Action Potential and Increased Arrhythmogenicity.
Valtonen J; Prajapati C; Cherian RM; Vanninen S; Ojala M; Leivo K; Heliö T; Koskenvuo J; Aalto-Setälä K
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371654
[TBL] [Abstract][Full Text] [Related]
36. Translational investigation of electrophysiology in hypertrophic cardiomyopathy.
Flenner F; Jungen C; Küpker N; Ibel A; Kruse M; Koivumäki JT; Rinas A; Zech ATL; Rhoden A; Wijnker PJM; Lemoine MD; Steenpass A; Girdauskas E; Eschenhagen T; Meyer C; van der Velden J; Patten-Hamel M; Christ T; Carrier L
J Mol Cell Cardiol; 2021 Aug; 157():77-89. PubMed ID: 33957110
[TBL] [Abstract][Full Text] [Related]
37. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
38. Serum supplemented culture medium masks hypertrophic phenotypes in human pluripotent stem cell derived cardiomyocytes.
Dambrot C; Braam SR; Tertoolen LG; Birket M; Atsma DE; Mummery CL
J Cell Mol Med; 2014 Aug; 18(8):1509-18. PubMed ID: 24981391
[TBL] [Abstract][Full Text] [Related]
39. Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice.
Chai AC; Cui M; Chemello F; Li H; Chen K; Tan W; Atmanli A; McAnally JR; Zhang Y; Xu L; Liu N; Bassel-Duby R; Olson EN
Nat Med; 2023 Feb; 29(2):401-411. PubMed ID: 36797478
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient iPSC-Derived Cardiomyocytes with MT-RNR2 Mutation.
Li S; Pan H; Tan C; Sun Y; Song Y; Zhang X; Yang W; Wang X; Li D; Dai Y; Ma Q; Xu C; Zhu X; Kang L; Fu Y; Xu X; Shu J; Zhou N; Han F; Qin D; Huang W; Liu Z; Yan Q
Stem Cell Reports; 2018 Mar; 10(3):808-821. PubMed ID: 29456182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]